Barclays’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-113,700
Closed -$3.63M – 5727
2026
Q2
$3.63M Buy
+113,700
New +$3.76M ﹤0.01% 2015

Other funds holding TYRA

Barclays's TYRA Position: Q3 2026 in Review

Barclays increased its Tyra Biosciences (TYRA) stake by 23% in Q3 2026, buying an estimated $126K and bringing the position to 24,841 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.

Barclays first reported a position in TYRA in Q1 2022 and has held it in 19 quarters since. The position peaked at $31.9M in Q1 2026. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Barclays held 24,841 shares of Tyra Biosciences worth $543K as of Q3 2026.
  • Barclays bought 4,566 Tyra Biosciences shares in Q3 2026, an estimated $126K.
  • Tyra Biosciences made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3409 holding.
  • Barclays first reported a position in Tyra Biosciences in Q1 2022 and has held it in 19 quarters since.
  • Barclays's Tyra Biosciences position peaked at $31.9M in Q1 2026.
  • 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.